- PCMH News
- Quality & Affordability
- Clinical Resources
Clinical Practice Guidelines
|The Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma was released in August 2007, by the National Heart, Lung, and Blood Institute (NHLBI) and the National Asthma Education and Prevention Program (NAEPP). The entire report can be found at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm.|
Autism Spectrum Disorder
|Visit http://www.goldcopd.org/ and search "Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018."|
Chronic Kidney Disease
Colorectal Cancer Screening
Coronary Artery Disease
Diabetes Testing During Pregnancy
Diabetes testing for all pregnant women with risk factors for type 2 diabetes (ADA2010).
Test all pregnant women not previous known to have diabetes using 75-gram oral glucose tolerance test (0GTT) between 24-28 weeks gestation—using diagnostic cutpoints of greater than 92mg/dl for the fasting glucose test; greater than 180 mg/dl 1 hour after drinking the 75-gram glucose solution; & greater 153 mg/dl 2 hours after drinking the glucose solution (ADA 2010). A screening test consisting of a 50-g, 1-hour GCT at 24 to 28 weeks’ gestation. Universal screening using the GCT is the most sensitive approach; however, women classified as low risk may not benefit from testing. It is left to the individual clinician to determine the feasibility of testing each pregnant woman (ACOG).